Replies to post #209494 on Biotech Values

[DewDiligence]

Re: RVNC liquidity /ATM facility

RVNC showed admirable restraint in not tapping the ATM until after the stock rose 60% following the US presidential election.

After issuing $10.1M of stock via the ATM during Jan-Feb 2017 (#msg-129082590), $64.9M of the original $75M remains available (http://www.sec.gov/Archives/edgar/data/1479290/000119312516495444/d148689d8k.htm ).

On today’s CC, the CFO said RVNC will continue to be “judicious” in tapping the ATM to avoid unnecessary dilution.

The above mindset about dilution should be automatic, but there are some biotech companies we know who are less shareholder-friendly in this regard.